← Leaderboards
Xiaoyi Yuan
University Of Texas Hlth Sci Ctr Houston
$2,653,973
Attributed
$3,679,945
Total exposure
2
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1.2M · FY2022–25$2M$1.5M$1M$500K$0
'22
'23
'24
'25
Funding mix
By agency
NIH$3,679,945 · 2
By mechanism
R01$3,679,945 · 2
Top collaborators
- Holger K. Eltzschig3 shared
Most similar at University Of Texas Hlth Sci Ctr Houston
Same institution · by research overlap
- William Dowhan$16,071,319
- Holger K. Eltzschig$19,015,874
- Sheng Zhang$5,447,789
- Michael C Braun$2,940,824
- Fudong Liu$7,013,711
Others in their field
Other Rising Stars on “Inflammation”
- Supriya Menezes · The Emmes Company, Llc$25,277,032
- Sabrina Paganoni · Massachusetts General Hospital$11,004,714
- Suma Babu · Massachusetts General Hospital$11,004,714
- Bruxanne El-Kammash · University Of Chicago$7,281,050
- Yanling Wang · Rush University Medical Center$5,926,468
- Caroline Uhler · Broad Institute, Inc.$5,265,486
Research focus
InflammationMicrornasGenetic TranscriptionMediatingHypoxia Inducible FactorIn VivoResponseOverexpressionAcute Respiratory Distress SyndromeInfectionIn VitroLungLung InfectionsRegulationRepressionAttenuatedGeneticPathway InteractionsDesignAnti-Inflammatory AgentsClinical TrialsMouse ModelLung InjuryPseudomonas Aeruginosa
Grant awards (8)
Functional Role of HIF-PHDs in ARDS$678,102
R01 · FY2025 · HL
Targeting Myeloid Dependent MicroRNAs in Acute Respiratory Distress Syndrome$390,000
R01 · FY2025 · HL · contact PI
Functional Role of HIF-PHDs in ARDS$664,541
R01 · FY2024 · HL
Targeting Myeloid Dependent MicroRNAs in Acute Respiratory Distress Syndrome$390,000
R01 · FY2024 · HL · contact PI
Functional Role of HIF-PHDs in ARDS$709,302
R01 · FY2023 · HL
Targeting Myeloid Dependent MicroRNAs in Acute Respiratory Distress Syndrome$390,000
R01 · FY2023 · HL · contact PI
Targeting Myeloid Dependent MicroRNAs in Acute Respiratory Distress Syndrome$68,000
R01 · FY2023 · HL · contact PI
Targeting Myeloid Dependent MicroRNAs in Acute Respiratory Distress Syndrome$390,000
R01 · FY2022 · HL · contact PI